Klein Dov's Form 4 filing
Fortress Biotech, Inc. (FBIO) · filed Apr 29, 2022
- Accession no.
- 0001104659-22-053625
- Filed
- Apr 29, 2022
- Trade date
- Aug 5, 2021-Jan 1, 2022
- Filing delay
- 267 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $12.3K. It was filed 267 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein DovCIK 0001647971 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Common Stock, par value $0.001 | JOtherAcquired | +305 | $0.00 | $0 | 655,305 | Direct | |
| Sep 30, 2021 | Common Stock, par value $0.001 | JOtherAcquired | +480 | $0.00 | $0 | 655,785 | Direct | |
| Nov 16, 2021 | Common Stock, par value $0.001 | JOtherAcquired | +230 | $0.00 | $0 | 656,015 | Direct | |
| Dec 28, 2021 | Common Stock, par value $0.001 | SSaleDisposed | −5,000 | $2.45 | −$12,250 | 651,015 | Direct | |
| Jan 1, 2022 | Common Stock, par value $0.001 | AGrant or awardAcquired | +100,000 | $0.00 | $0 | 751,015 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.